Skip to main content
Year archive

Fredun Pharmaceuticals Limited — 2026 filings

All 44 regulatory filings released by Fredun Pharmaceuticals Limited (539730) in 2026, sourced directly from the official regulator.

44 Filings
2026 Period
2026 filings (44)
Filing Released Lang
Fredun Pharmaceuticals Limited Unveils Cellular Longetivity Dedicated Platform Daulcel
Regulatory Filings
2026-05-15 English
Fredun Pharmaceuticals Limited announces Strategic Launch of Hormone Range Products.
Regulatory Filings
2026-05-15 English
Monitoring Agency report for the quarter ended 31st March 2026.
Capital/Financing Update
2026-05-15 English
The Board of Directors of the Company at their Board Meeting held on Friday, May 15, 2026 at 07:30 P.M through Video Conferencing (VC) inter alia transacted the following businesses: 1. ....
Regulatory Filings
2026-05-15 English
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve 1. Consider and approve ....
Regulatory Filings
2026-05-15 English
Please find enclosed press release titled "Fredun Pharmaceuticals Expands Manufacturing Base with Fifty Facility at Palghar" issued by Fredun Pharmaceuticals Limited.
Regulatory Filings
2026-04-29 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2026-04-28 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fredun Nariman Medhora & Others
Regulatory Filings
2026-04-15 English
Disclousre Under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015.
Regulatory Filings
2026-04-13 English
Allotment of 40,000 Equity Shares to Promoter upon conversion of Warrants into Equity Shares
Regulatory Filings
2026-04-09 English
Allotment of 40,000 Equity Shares to Promoter upon conversion of Warrants into Equity Shares
Regulatory Filings
2026-04-09 English
Allotment of 40,000 Equity Shares to Promoter upon conversion of Warrants into Equity Shares
Regulatory Filings
2026-04-09 English
In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018; we furnish hereunder certificate dated 01st April,2026 received from the SEBI registered RTA ....
Regulatory Filings
2026-04-06 English
Closure of Trading Window from 1st April 2026 till 48 hours after the end of the Board Meeting wherein, Approval of Audited Financial Results for the quarter and year ended 31st March,2026.
Regulatory Filings
2026-03-26 English
Disclosure under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015.
Regulatory Filings
2026-03-26 English
Outcome of the Analyst/Investors Meet.
Regulatory Filings
2026-03-25 English
Allotment of 106668 Equity Shares to Promoter upon conversion of warrants into Equity Shares.
Regulatory Filings
2026-03-25 English
Allotment of 106668 Equity Shares to Promoter upon conversion of warrants into Equity Shares.
Regulatory Filings
2026-03-25 English
Allotment of 1,06,668 Equity Shares to Promoter upon conversion of Warrants into Equity Shares
Regulatory Filings
2026-03-25 English
Intimation of Investor/Analyst Meeting under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Regulatory Filings
2026-03-21 English
Intimation On Investor Meeting under reg 30 of SEBI (LODR) Reg, 2015 on 18th March, 2026.
Regulatory Filings
2026-03-16 English
Analyst/Institutional Investors meeting held on Wednesday, 11th March 2026 organised by Arihant Capital - Bharat Connect Conference Rising Star 2026.
Regulatory Filings
2026-03-12 English
Intimation of Schedule of ''Bharat Connect Conference'', under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015.
Regulatory Filings
2026-03-05 English
Press Release titled Infomerics Upgrade Fredun Pharmaceuticals Credit Rating to BBB+, Boosts Financial Profile.
Regulatory Filings
2026-02-25 English
Press Release tiltled Infomerics Upgrade Fredun Pharmaceuticals Credit Rating to BBB+, Boosts Financial Profile.
Regulatory Filings
2026-02-25 English
Transcript of Earnings Call held on 12th February, 2026 for Q3 and 9 months FY 2026.
Regulatory Filings
2026-02-17 English
Appointment of Mrs. Pooja Sanghavi as a Non-Executive Independent Director.
Regulatory Filings
2026-02-16 English
SCRUTINIZER''S REPORT ON REMOTE E-VOTING AND E-VOTING.
Regulatory Filings
2026-02-16 English
Outcome Of Extra Ordinary General Meeting of the Company.
Regulatory Filings
2026-02-16 English
Statement of Deviation or Variation for the Quarter Ended December 31, 2026
Regulatory Filings
2026-02-14 English
Report of Monitoring Agency for the Quarter Ended December 31, 2026
Regulatory Filings
2026-02-14 English
Outcome of the Board Meeting held on Saturday, February 14, 2026 at 05:00 P.M through Video Conferencing (VC)
Regulatory Filings
2026-02-14 English
Pursuant to Regulation 30 read with Sub para 15, Para A Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the ....
Regulatory Filings
2026-02-12 English
Newspaper Advertisement of the Financial Statements Quarter ended & Nine months ended 31st December, 2025.
Regulatory Filings
2026-02-11 English
Revised Outcome
Regulatory Filings
2026-02-09 English
Intimation of Earnings Conference Call for the quarter ended 31st December, 2025.
Regulatory Filings
2026-02-09 English
Un-Audited Financial Results of the Company for the Quarter and Nine Months Ended 31st December, 2025
Regulatory Filings
2026-02-09 English
Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 we wish to inform you that the Board of Directors of the Company at its meeting ....
Regulatory Filings
2026-02-09 English
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and approve Intimation is hereby ....
Regulatory Filings
2026-01-30 English
Intimation of book closure.
Regulatory Filings
2026-01-20 English
Disclosure under Regulation 30 of SEBI (LODR) Regulation, 2015 - copy of newspaper advertisement.
Regulatory Filings
2026-01-20 English
Notice Convening EGM of the Company
Regulatory Filings
2026-01-19 English
Newspaper Clipping-Information regarding EGM to be held on 16.02.2026
Regulatory Filings
2026-01-15 English
Certificate pursuant to Regulation 74(5) of SEBI (Depositories and participants) Regulations, 2018.
Regulatory Filings
2026-01-13 English